PHARMACEUTICAL COMPOSITION OF METFORMIN DECAVANADATE FOR THE PREVENTION AND TREATMENT OF METABOLIC SYNDROME, OBESITY AND TYPE 2 DIABETES.

摘要

The present disclosure is related to a process for the production of the metformin-vanadium compound, as well as for a pharmaceutical composition comprising metformin-vanadium, which is useful for the treatment of obesity, type 2 diabetes mellitus, and metabolic syndrome.